Owen Adams Catherine
SEC insider (Form 3/4/5 filer). CIK 0001816838. Director at AGIOS PHARMACEUTICALS, INC. (AGIO) and 1 other issuer. 15 reported Form 4/5 transactions since Sep 2024; latest on Jun 18, 2026. Located in CAMBRIDGE, MA.
Companies Owen Adams Catherine has filed insider reports for
- AGIOS PHARMACEUTICALS, INC. (AGIO): Director
- ACADIA PHARMACEUTICALS INC (ACAD): Director, Officer, Chief Executive Officer
Owen Adams Catherine
CIK: 0001816838
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Jun 18, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
AwardDirectStock options (right to buy)
15K shares- - Jun 18, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
ExerciseDirect2.8K shares- - Jun 18, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
AwardDirectRestricted stock units
2.9K shares- - Jun 13, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
ExerciseDirect2K shares- - Mar 25, 2026ACAD
ACADIA PHARMACEUTICALS INC
SaleDirect11.6K shares at avg. $21.47$250K - Mar 24, 2026ACAD
ACADIA PHARMACEUTICALS INC
ExerciseDirect23.5K shares- - Mar 6, 2026ACAD
ACADIA PHARMACEUTICALS INC
AwardDirectRestricted Stock Units
76.5K shares- - Mar 6, 2026ACAD
ACADIA PHARMACEUTICALS INC
AwardDirectStock Option (Right to Buy)
263K shares- - Jun 20, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
ExerciseDirect2.1K shares- - Jun 18, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
AwardDirectStock options (right to buy)
15.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 18, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Award Stock options (right to buy) | 14,950 | - | - | Direct |
| Jun 18, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise | 2,816 | - | $0 | Direct |
| Jun 18, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Award Restricted stock units | 2,927 | - | - | Direct |
| Jun 13, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise | 1,976 | - | $0 | Direct |
| Mar 25, 2026 | ACAD ACADIA PHARMACEUTICALS INC | Sale | 11,641 | $21.47 | $249,932 | Direct |
| Mar 24, 2026 | ACAD ACADIA PHARMACEUTICALS INC | Exercise | 23,509 | - | $0 | Direct |
| Mar 6, 2026 | ACAD ACADIA PHARMACEUTICALS INC | Award Restricted Stock Units | 76,509 | - | - | Direct |
| Mar 6, 2026 | ACAD ACADIA PHARMACEUTICALS INC | Award Stock Option (Right to Buy) | 263,005 | - | - | Direct |
| Jun 20, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise | 2,120 | - | - | Direct |
| Jun 18, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Award Stock options (right to buy) | 15,768 | - | - | Direct |
1-10 of 15 transactions